BEVACIZUMAB

Información Básica

Elemento Valor
DrugBank ID DB00112
Nivel de Evidencia L5 (Predicción Computacional)
Número de Indicaciones Predichas 20

Indicaciones Predichas (TxGNN)

Las siguientes son posibles nuevas indicaciones predichas por el modelo TxGNN. Puntuaciones más altas indican mayor relevancia predicha.

# Indicación Fuente
1 primary peritoneal serous/papillary carcinoma TxGNN Knowledge Graph
2 malignant epithelial tumor of ovary TxGNN Knowledge Graph
3 squamous cell carcinoma of the corpus uteri TxGNN Knowledge Graph
4 hereditary breast carcinoma TxGNN Knowledge Graph
5 fallopian tube cancer TxGNN Knowledge Graph
6 cervical carcinoma TxGNN Knowledge Graph
7 breast cancer TxGNN Knowledge Graph
8 undifferentiated carcinoma of the corpus uteri TxGNN Knowledge Graph
9 primary malignant peritoneal tumor TxGNN Knowledge Graph
10 cervical cancer TxGNN Knowledge Graph
11 fallopian tube carcinoma TxGNN Knowledge Graph
12 breast neoplasm TxGNN Knowledge Graph
13 glioma susceptibility TxGNN Knowledge Graph
14 primary peritoneal carcinoma (disease) TxGNN Knowledge Graph
15 peritoneum cancer TxGNN Knowledge Graph
16 desmoplastic small round cell tumor TxGNN Knowledge Graph
17 cervical adenocarcinoma TxGNN Knowledge Graph
18 glioblastoma (disease) TxGNN Knowledge Graph
19 metastatic malignant neoplasm in the colon TxGNN Knowledge Graph
20 hereditary breast ovarian cancer syndrome TxGNN Knowledge Graph

Descargo de Responsabilidad

Estas predicciones son solo para fines de investigación y no constituyen consejo médico. Se requiere validación clínica antes de cualquier aplicación clínica.


← Volver a Búsqueda de Medicamentos


Back to top

Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.